Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Akasa
AddedFeb 15, 2024
UpdatedJun 18, 2026
Akasa

Akasa

Series B

San Francisco-based AKASA provides AI-powered automation for healthcare revenue cycle management.

HQ
San Francisco, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in San Francisco, AKASA is dedicated to transforming healthcare revenue cycle management through AI-powered automation. Their core mission is to streamline administrative processes in healthcare, reducing costs and improving efficiency. AKASA offers solutions that automate complex billing and coding tasks, ensuring accuracy and compliance while freeing up healthcare professionals to focus on patient care. The company targets healthcare providers and systems, aiming to enhance operational efficiency and financial performance.

Notable affiliates include Matt Morgan, CFO at Montage Health, and Jeff Francis, Vice President and CFO at Methodist Health System. AKASA has garnered significant attention for its innovative approach, securing investments from prominent venture capital firms. Key achievements include successful integrations with major healthcare systems and demonstrable improvements in revenue cycle metrics for clients. Overall, AKASA's impact lies in its ability to reduce administrative burdens, lower operational costs, and improve the financial health of healthcare organizations.

Akasa - Products & Services

  • AKASA Healthcare GenAI RCM Solution logo

    AKASA Healthcare GenAI RCM Solution

    Generative AI platform automating healthcare revenue cycle tasks from prior authorization to claims management.

    Competing Products

    Adonis logo
    Adonis logo

Akasa - Similar Companies

Adonis logo

Adonis

adonis.io

Thoughtful AI logo

Thoughtful AI

thoughtful.ai

Shasta Health logo

Shasta Health

shasta.health

AZmed logo

AZmed

azmed.co

Sohar Health logo

Sohar Health

soharhealth.com

Element5 logo

Element5

e5.ai

Asclepius Health logo

Asclepius Health

tryasclepius.com

Hank AI logo

Hank AI

hank.ai

Vispa logo

Vispa

vispaflow.com

Lassie logo

Lassie

lassie.ai

Autonomous Healthcare logo

Autonomous Healthcare

Ascertain logo

Ascertain

ascertain.com

Basata logo

Basata

basata.ai

Pelica Health logo

Pelica Health

pelica.com

Notable Health logo

Notable Health

notablehealth.com

Akasa - Quick Facts

Who are Akasa's competitors?

Companies similar to Akasa include Adonis, Thoughtful AI, Shasta Health and AZmed.

When was Akasa founded?

Akasa was founded in 2018.

Where is Akasa's headquarters located?

Akasa's headquarters is located in San Francisco, CA, US.

When was Akasa's last funding round?

Akasa's most recent funding round was for $60M (USD) in March 2021.

How much has Akasa raised to-date?

As of Mar 23, 2021, Akasa has raised a total of $85M (USD).

How many employees does Akasa have?

Akasa has 235 employees as of Feb 4, 2024.

Akasa - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Tags
  • AI Operations
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software